JAK1 V658F, homologous mutation to JAK2 V617F described below, has been identified in adult T- and B-ALL and shown to lead to constitutive JAK1 activation in cell lines [60,61,62]. The gene discussed is JAK1; the disease is acute lymphoblastic leukemia.